SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant volatility and trending momentum as investors closely monitor upcoming blockchain upgrades and potential token burn events. The community remains deeply divided, with many traders speculating on a supply shock and potential price recovery while skeptics warn of pump-and-dump risks.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as community members aggressively debate whether the token is primed for a new all-time high or if it is entering a period of exhaustion. Bullish traders are actively calling for others to hold through dips and push for higher volume, while skeptics warn of potential rug pulls and shift their attention to emerging meme coins.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending due to excitement surrounding its electro-optic polymer technology, with investors actively discussing potential integration into data centers and high-speed AI infrastructure through partnerships. The community remains highly focused on monitoring for commercialization catalysts and significant contract announcements, while debating the stock's valuation as it experiences increased trading volume and volatility.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The $ROAR token is seeing intense community-driven momentum as investors draw parallels between its community-led project model and the broader GameStop market sentiment. Discussions are dominated by speculation regarding potential exchange listings and the ongoing strength of the Roaring Kitty narrative, with holders emphasizing the project's decentralized, community-owned structure.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is generating strong community interest driven by its position as a key infrastructure layer for AI-integrated blockchain applications and its rising utility in cross-chain intents. Traders are actively discussing the protocol's fundamental strength and price compression as a potential setup for an upward breakout.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as investors react to the companys recent announcement regarding the preliminary Phase 3 trial design for CAD-1005 in patients with Heparin-Induced Thrombocytopenia. While some community members are highlighting the clinical pipeline and long-term potential of the company's anti-thrombotic programs, others are actively debating concerns regarding share dilution and the heavy volume of automated posts surrounding the stock.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community maintains a patient, long-term outlook, frequently discussing the project's 'move-to-earn' utility and potential for a future breakout. Despite recent downward pressure, many supporters are actively accumulating while highlighting their commitment to the ecosystem's long-term growth and fitness-focused mission.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

The JPMorgan Equity Premium Income ETF ($JEPI) remains a central focus for income-oriented investors, with recent community sentiment driven by its ability to provide monthly cash flow distributions amid broader market volatility. Investors are actively discussing the strategy's utility as a portfolio stabilizer and income generator, often comparing it to $JEPQ and other derivative-income funds to evaluate trade-offs between yield, tax treatment, and capital preservation.

Crexendo, Inc. engages in the provision of telecommunications services, broadband Internet services, and other cloud business services. It operates through the Cloud Telecommunications Services and Software Solutions segments. The Cloud Telecommunications Services segment focuses on selling cloud telecommunication products and services and broadband Internet services. The software solutions segment focuses on software licenses, software maintenance support and professional services. The company was founded on April 13, 1995 and is headquartered in Tempe, AZ.

Crexendo Inc

Crexendo is seeing significant community interest driven by consistent earnings beats and the company's expanding market share in the UCaaS space, particularly as competitors like Cisco and Microsoft shift their focus away from similar platforms. Investors are closely monitoring its recurring revenue growth, AI-powered feature integrations, and potential for future accretive acquisitions as the firm cements its position in the cloud communications market.

BioLLM

BioLLM is gaining traction as a new project in the bio-computing space, with the community actively discussing its unique integration of living neural cultures into AI language models. Supporters are highlighting the upcoming release of its iOS application and the novelty of its biological-digital intelligence approach while frequently linking the token to broader AI and tech sector market sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or...

Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC

Anebulo Pharmaceuticals Announces Final Results of Tender Offer

Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer

How Is The Market Feeling About Anebulo Pharmaceuticals Inc?

Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer

Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading 0.8% Higher - Still a Buy?

Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Up 0.8% - Here's Why...

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.

Current Price	$0.46
Prev Close	$0.44
Open	$0.45
Dividend Yield	0.00%
50-Day Moving Average	$0.6067
Beta	0.09
Avg. Volume	4,920.76
PE Ratio	-2.37

52-Week High	$3.42
52-Week Low	$0.2999
Market Capitalization	$18.76M
EPS (Annual)	-$0.2509
Price to Book	2.38
Revenue Per Employee	$0.00

ANEB
Anebulo Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANEB News

ANEBAnebulo Pharmaceuticals Inc